AbbVie Inc.
NYSE:ABBV
$ 138.32
+ $4.11 (3.06%)
$ 138.32
+ $4.11 (3.06%)
End-of-day quote: 10/03/2022

ABBV - AbbVie Stock Prediction 2025 - 2030

10 years of reliable AbbVie stock forecast. The Wall Street analysts predict Outperform for ABBV. See at a glance whether NYSE:ABBV will rise in the future.

$151.59
Forecast 2022
$140.77
Forecast 2025
$154.94
Forecast 2030
Neutral
TopGraphs Quality Ranking
Forecast 2022
$151.59
Forecast 2025
$140.77
Forecast 2030
$154.94
TopGraphs Quality Ranking
Neutral

AbbVie Stock Forecast 2022

$156.00

In the last five quarters, AbbVie's Price Target has risen from $125.98 to $164.23 - a respectable 30.36% increase. Nineteen analysts expect AbbVie's share price to fall slightly in the coming year and give 156.00 as a price target. This would correspond to an decrease of -5.01%.

12.78%
12.78

Highest Price Target $200.00

Average Price Target $156.00

Lowest Price Target $120.00

AbbVie Stock Predictions 2025

Stock Forecast for the Price of an AbbVie Share in Jan 2025.

In January 2025, analysts believe the stock price will be $130.65. An increase of 5.54% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in Feb 2025.

In February 2025, analysts believe the stock price will be $131.57. An increase of 4.88% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in Mar 2025.

In March 2025, analysts believe the stock price will be $132.49. An increase of 4.21% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in Apr 2025.

In April 2025, analysts believe the stock price will be $133.41. An increase of 3.55% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in May 2025.

In May 2025, analysts believe the stock price will be $134.33. An increase of 2.88% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in Jun 2025.

In June 2025, analysts believe the stock price will be $135.25. An increase of 2.22% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in Jul 2025.

In July 2025, analysts believe the stock price will be $136.17. An increase of 1.55% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in Aug 2025.

In August 2025, analysts believe the stock price will be $137.09. An increase of 0.89% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in Sep 2025.

In September 2025, analysts believe the stock price will be $138.01. An increase of 0.22% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in Oct 2025.

In October 2025, analysts believe the stock price will be $138.93. An increase of 0.44% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in Nov 2025.

In November 2025, analysts believe the stock price will be $139.85. An increase of 1.11% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in Dec 2025.

In December 2025, analysts believe the stock price will be $140.77. An increase of 1.77% compared to the previous month's estimate.

AbbVie Stock Prediction 2030

Stock Prediction for the Price of One AbbVie Share in Jan 2030.

In Jan 2030 analysts predict a share price of $157.52. An increase of 13.88% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in Feb 2030.

In Feb 2030 analysts predict a share price of $157.29. An increase of 13.71% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in Mar 2030.

In Mar 2030 analysts predict a share price of $157.05. An increase of 13.54% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in Apr 2030.

In Apr 2030 analysts predict a share price of $156.82. An increase of 13.37% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in May 2030.

In May 2030 analysts predict a share price of $156.58. An increase of 13.2% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in Jun 2030.

In Jun 2030 analysts predict a share price of $156.35. An increase of 13.03% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in Jul 2030.

In Jul 2030 analysts predict a share price of $156.11. An increase of 12.86% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in Aug 2030.

In Aug 2030 analysts predict a share price of $155.88. An increase of 12.7% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in Sep 2030.

In Sep 2030 analysts predict a share price of $155.65. An increase of 12.53% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in Oct 2030.

In Oct 2030 analysts predict a share price of $155.41. An increase of 12.36% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in Nov 2030.

In Nov 2030 analysts predict a share price of $155.18. An increase of 12.19% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in Dec 2030.

In Dec 2030 analysts predict a share price of $154.94. An increase of 12.02% compared to today's share price.

Company Info

P/E Ratio
10.8
Beta
0.65
Price-to-book Ratio
16.69
Market Cap
244.56B
TEV
319.705 B
LT Debt/Cap
0.07%
Dividend
$5.81
Div Yld
4.20%
Forecast 1Y
15.23%
Forecast 2Y
4.27%
Analyst Price Target
$164.23
Website

About AbbVie

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide.

AbbVie Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
10.8
Beta
0.65
Price-to-book Ratio
16.69
Market Cap
244.56B
TEV
319.705 B
LT Debt/Cap
0.07%
Dividend
$5.81
Div Yld
4.20%
Forecast 1Y
15.23%
Forecast 2Y
4.27%
Analyst Price Target
$164.23
Website

Financials

Year Year 2020 2021
Rev. Revenue
45804.00 56197.00
GM % Gross Margin %
69.3 69.2
OI Operating Income
15699.00 19529.00
OM Operating Margin
34.27 34.75
NI Net Income
4616.00 11542.00
EPS % Earnings Per Share %
10.56 12.7
Div. Dividends
4.84 5.31
PR % Payout Ratio %
45.83 41.81
Sha. Shares
1765 1768
OCF Operating Cash Flow
17588 22777
CS Cap Spending
-798 -787
FCF Free Cash Flow
16790 21990
FCFS Free Cash Flow Per Share
10.07 12.42

AbbVie Analyst Ratings Frequently Asked Questions

Who are the analysts watching AbbVie Inc.?

The following analysts have recently covered AbbVie:

Argus Research Company
Atlantic Equities LLP
Baptista Research
Barclays
Berenberg
BMO Capital Markets Equity Research
BofA Global Research
CFRA Equity Research
Citigroup Inc
Citigroup Inc. Research
Cowen and Company
Daiwa Securities Co. Ltd.
Day By Day
Evercore ISI
Goldman Sachs
J.P. Morgan
Marktfeld
Moody’s
Morgan Stanley
Morningstar Inc.
Piper Sandler Companies
Redburn
Societe Generale Cross Asset Research
Truist Securities
Vermilion Research
Wells Fargo Securities, LLC
Wolfe Research, LLC.
SVB Securities LLC
Capital Alpha Partners, LLC
UBS Investment Bank
(This information refers to the last 90 days.)

Who are the sell-side analysts watching AbbVie Inc.?

The following sell-side analysts have recently covered AbbVie:

Chesney, Steven Kent
Majumdar, Ishan
Gould, Carter Lewis
Hector, Luisa Caroline
Nachman, Gary Jay
Meacham, Geoffrey Christopher
Glickman, Stewart
Baum, Andrew Simon
Scala, Stephen Michael
Nakagiri, Narumi
Schimmer, Joshua Elliott
Shibutani, Chris
Paraskevopoulos, Michail
Conover, Damien
Raymond, Christopher Joseph
Smith, Justin Steven Barrie
Karnauskas, Robyn Kay Shelton
Nicoski, David P.
Bansal, Mohit
Anderson, Timothy Minton
Flynn, Terence C.
Hellweg, Jasper
Risinger, David Reed
Gastaldy, Valérie
Baker, Simon P.
Bristow, Colin Nigel
Kumaar, Mohit
Smith, Rob
Schott, Christopher Thomas
(This information refers to the last 90 days.)

© Copyright 2022 | TopGraphs™ | All Rights Reserved

To use TopGraphs™, you must accept our Terms and Conditions and Privacy Policy